目的 分析2010—2014年天津中醫(yī)藥大學(xué)附屬第二醫(yī)院中藥注射劑的使用情況,為促進(jìn)臨床合理用藥提供依據(jù).方法 回顧性調(diào)查天津中醫(yī)藥大學(xué)附屬第二醫(yī)院2010—2014年中藥注射劑的使用情況,計(jì)算藥品的銷售金額、用藥頻度(DDDs)、日均費(fèi)用(DDC)及銷售金額排序(B)和DDDs排序(A)的比值(B/A).結(jié)果 2010—2014年,中藥注射劑品種構(gòu)成相對穩(wěn)定,以心腦血管類為主;心腦血管類與清熱解毒類中藥注射劑構(gòu)成了DDDs與銷售金額排名的前10位,單品種用藥金額與DDDs排序變化較大;在DDDs排名前10位的藥品中,大部分品種的DDC在100元以上;大多數(shù)中藥注射劑品種的B/A接近1,用藥同步性較好.結(jié)論 天津中醫(yī)藥大學(xué)附屬第二醫(yī)院中藥注射劑的應(yīng)用基本合理,但患者經(jīng)濟(jì)負(fù)擔(dān)較重,應(yīng)注意加強(qiáng)管理.

Objective To analyze the utilization of traditional Chinese medicine (TCM) injections in Second Affiliated Hospital of Tianjin University of TCM from 2010 to 2014, in order to provide reference for clinical rational use of drugs. Methods Retrospective investigation method was used. The consumption sum, daily defined doses (DDDs), average daily cost (DDC), and the ratio (B/A) of sequence of consumption sum (B) and sequence of DDDs in Second Affiliated Hospital of Tianjin University of TCM from 2010 to 2014 were analyzed statistically. Results From 2010 to 2014, species composition of TCM injections were relatively stable, and mainly were cardiovascular and cerebrovascular. DDDs and consumption sum of top 10 TCM injections were comprised with cardiovascular and cerebrovascular and antipyretic and antidotal TCM injections. Sortings of DDDs and consumption sum had not great changes. In DDDs of top 10 TCM injections, DDC of most TCM injections were above 100 RMB. B/A values of most TCM injections were almost 1. The synchronicity was better. Conclusion The application of TCM injections in Second Affiliated Hospital of Tianjin University of TCM is basically rational. However, economic burden of patients is heavy, which needs further efforts to strengthen the management.